Results

Total Results: 2,231 records

Showing results for "medication".
Users also searched for: medication reconciliation

141. Final Recommendation Statement: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Share to Email Print Final Recommendation Statement Breast Cancer: Medication … Duration of Medication Use and Persistence of Effects In trials, participants typically used risk-reducing … Based on limited survey data, 10% to 30% (depending on medication type) of primary care clinicians report … Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the … Medication use for the risk reduction of primary breast cancer in women: updated evidence report and

142. Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/2wL_PmXmBxZQXX29D7nma5
     September 01, 2021 - www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication … recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication

143. Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 26, 2019 - Research Plan Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … Comparisons Placebo or no treatment Any active substance or intervention (e.g., nonaspirin medication

144. Let’s Talk About It: Discussion Guides | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/lets-talk-about-it-discussion-guides
     April 01, 2024 - lists important questions for patients to ask their healthcare professionals about this preventive medication … recommendation, including information geared toward healthcare professionals about who should take this medication

145. Clinical Summary: Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/kQWppPe7wLrdrHnbqM2BQu
     December 05, 2017 - Preventive Medication Hormone therapy refers to the use of combined estrogen and progestin in women … at increased risk of breast cancer who do not have contraindications and are at low risk of adverse medication

146. Final Recommendation Statement: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/RecommendationStatementFinal/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - Recommendation Statement Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … Treatment or Intervention Interventions to manage preeclampsia, such as antihypertensive medication … the 2014 recommendation, the USPSTF recommended the use of low-dose aspirin (81 mg/d) as preventive medication … Benefits of Risk Assessment and Preventive Medication The USPSTF considered 18 randomized clinical … Harms of preventive medication There is adequate evidence to bound the harms of low-dose aspirin as

147. Final Research Plan: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan108/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
     October 16, 2014 - Final Research Plan Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication

148. Understanding Task Force Draft Recommendations (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/GrmsAapkcjE-bN9GqjaSkF
     November 08, 2021 - These may include a patient’s preference for taking a daily medication. … draft-update-summary/aspirin-use-to-prevent-cardiovascular-disease-and-colorectal-cancer-preventive-medication … draft-update-summary/aspirin-use-to-prevent-cardiovascular-disease-and-colorectal-cancer-preventive-medication … draft-update-summary/aspirin-use-to-prevent-cardiovascular-disease-and-colorectal-cancer-preventive-medication

149. PowerPoint Presentation (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-06/USPSTF-app-promotion-ppt-slide.pdf
     January 01, 2024 - • This app helps healthcare professionals identify which screening, counseling, and preventive medication

150. Carol M. Mangione, M.D., M.S.P.H. | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/carol-m-mangione-md-msph
     March 01, 2022 - Mangione is the director of the “UCMyRx Medication Therapy Management Program,” which embeds clinical … pharmacists in primary care practices to enhance communication, educate, and improve medication adherence

151. Archived: Postmenopausal Hormone Replacement Therapy for Primary Prevention of Chronic Conditions: Evidence Summary: Menopausal Hormone Therapy: Preventive Medication, 2002 and 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/postmenopausal-hormone-replacement-therapy-for-primary-preve/menopausal-hormone-therapy-preventive-medication-2002-2005
     August 21, 2002 - Primary Prevention of Chronic Conditions: Evidence Summary Menopausal Hormone Therapy: Preventive Medication

152. PowerPoint Presentation (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-10/USPSTF-app-promotion-pptslide.pdf
     January 01, 2024 - • This app helps healthcare professionals identify which screening, counseling, and preventive medication

153. Archived: Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-february-2014
     February 15, 2014 - Final Recommendation Statement Vitamin Supplementation to Prevent Cancer and CVD: Preventive Medication … Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication … Effectiveness of Preventive Medication Multivitamin and Antioxidant Combinations The USPSTF reviewed … Potential Harms of Preventive Medication Overall, few significant harms were reported from these interventions

154. Final Research Plan: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/breast-cancer-medications-for-risk-reduction
     July 20, 2017 - Share to Email Print Final Research Plan Breast Cancer: Medication … KQ 1: Risk assessment methods vs. usual care or an alternative risk assessment method KQs 2–4: Medication

155. Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/-TsBkyewVoFpC7htRmzWJa
     September 03, 2019 - Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and … Systematic Review for the USPSTF Medication Use for the Risk Reduction of Primary Breast Cancer in … Symptomatic effects (eg, vasomotor, musculoskeletal) varied by medication. … with placebo per 1000 women, assuming 5 years of medication use, were estimated when the meta-analysis … for medication Harms of medication 3 4 2 4 1 Reduced incidence of invasive breast cancer Other

156. Archived: Final Evidence Summary: Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary53/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
     July 01, 2003 - Final Evidence Summary Vitamin Supplementation to Prevent Cancer and CVD: Counseling and Preventive Medication

157. Archived: Evidence Summary: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
     January 10, 2017 - archived Evidence Summary Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication … Page/Document/final-evidence-review146/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication … 4,293 619 4167 0.93 (0.82-1.06) BMI ≥30.0, low dietary folate intake, anticonvulsant medication

158. Integrating Evidence-Based Clinical and Community Strategies to Improve Health - Table 2 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/integrating-evidence-based-clinical-and-community-strategies-improve-health-table-2
     November 01, 2013 - Interventions Prevention Strategy Task Force Clinical     Screening, Counseling, Preventive Medication

159. High-Priority Evidence Gaps For Clinical Preventive Services: 7th Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annual-report-to-congress-2017%20(2).pdf
     January 01, 2017 - ocular topical medication for all newborns for the prevention of gonococcal ophthalmia neonatorum. … Preventive Services Task Force | 35 Grade Title B Breast Cancer: Preventive Medication in Women … For women who are at increased risk for breast cancer and at low risk for adverse medication effects … D Breast Cancer: Preventive Medication in Women Not at Increased Risk The USPSTF recommends against … I Vitamin D and Calcium to Prevent Fractures: High-Dose Preventive Medication in Postmenopausal Women

160. Behavioral and Pharmacotherapy Weight Loss Interventions to Prevent Obesity-Related Morbidity and Mortality in Adults: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/boPWHmzrtxnkkPQAoCNENS
     September 18, 2018 - weight loss interventions, and medication- based weight loss maintenance interventions). … Data from medication trials could not be pooled because of the small number of studies for each medication … Medication and placebo groups both received identical behavioral interventions. … The medication evidence was limited by the small number of trials for each medication, methodological … Weight Loss Results in All Medication-Based Weight Loss and Medication-Based Weight-Loss Maintenance